JY
BSTC

Jeff Yass’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Jeff Yass’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,556
Closed -$477K – 10417
2016
Q4 		$477K Buy
+8,556
New +$411K ﹤0.01% 7094
2013
Q4 		– Sell
-16,911
Closed -$329K – 9487
2013
Q3 		$329K Sell
16,911
-7,469
-31% -$132K ﹤0.01% 7080
2013
Q2 		$380K Buy
+24,380
New +$392K ﹤0.01% 6447

Other funds holding BSTC

JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Jeff Yass's BSTC Position: Q1 2017 in Review

Jeff Yass sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2017, closing a stake of 8,556 shares — an estimated $477K sold.

Jeff Yass first reported a position in BSTC in Q2 2013 and held it in 3 quarters. The position peaked at $477K in Q4 2016. 89 funds tracked by Wall St. Rank hold BSTC as of Q1 2017.

  • Jeff Yass reported no remaining BioSpecifics Technologies Corp. position as of Q1 2017 after selling out during the quarter.
  • Jeff Yass sold 8,556 BioSpecifics Technologies Corp. shares in Q1 2017, an estimated $477K.
  • Jeff Yass first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 3 quarters.
  • Jeff Yass's BioSpecifics Technologies Corp. position peaked at $477K in Q4 2016.
  • 89 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.